
GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES
93
Recent news items primarily cover commodity market movements and earnings call transcripts of other companies, with no direct developments reported for Greenway Technologies.
- Commodity markets including cattle, corn, cotton, soybeans, and others showed gains or strength in November 2026 [N1][N2][N4][N5][N6].
- Stock market movements included retreats in chipmakers and bond yields rising in November 2026 [N3].
- Earnings call transcripts for other companies such as SBC Medical and VolitionRx were published in November 2026 [N7][N8].
Greenway Technologies, Inc. develops proprietary gas-to-liquids (GTL) technology centered on its patented G-Reformer, which converts various natural gas streams into synthesis gas. This synthesis gas is then processed via Fischer-Tropsch reactors to produce ultra-clean synthetic fuels such as gasoline, diesel, jet fuel, methanol, and high-value chemicals. The company’s technology emphasizes modular, scalable, and portable GTL plants designed for smaller-scale, distributed deployment, differentiating it from large refinery-scale GTL operations. Greenway aims to reduce dependency on foreign chemical production by manufacturing high purity chemicals domestically. The company is in the development stage with limited operating history and has incurred significant losses. As of the latest filings, Greenway reported no revenue and faces liquidity constraints, with its going concern status dependent on raising additional capital or achieving profitable operations.
Greenway Technologies, Inc. is a development-stage company focused on proprietary gas-to-liquids (GTL) technology, including its patented G-Reformer unit that converts natural gas into synthesis gas for producing fuels and chemicals. The company has multiple patents and pending applications and aims to commercialize modular, scalable GTL plants primarily in the U.S. market. As of September 30, 2026, Greenway reported no revenue, a net loss of $400,896 for the quarter, and liquidity challenges with current liabilities significantly exceeding current assets. The company’s ability to continue as a going concern depends on achieving profitable operations or securing additional financing. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
Greenway Technologies has developed a unique and patented GTL technology that enables smaller, modular, and portable plants capable of processing various natural gas streams into clean fuels and high-value chemicals. The company’s technology addresses environmental concerns by reducing flaring and producing cleaner fuels. Its patent portfolio and licensing agreements provide a foundation for commercialization. The domestic production of high purity chemicals could meet industrial demand and reduce reliance on imports, potentially improving economic returns. If the company successfully raises capital and executes its commercialization strategy, it could establish a foothold in the emerging small-scale GTL market.
Greenway Technologies is a development-stage company with a limited operating history and no reported revenue as of the latest filings. The company has incurred significant losses and faces substantial liquidity challenges, with current liabilities far exceeding current assets. Its ability to continue operations depends on raising additional capital, which is uncertain and subject to market conditions. The GTL market is competitive with established large players, and the company’s technology has yet to achieve broad commercial adoption or third-party certification. Failure to secure financing or commercialize its technology could materially impair its business prospects.
Greenway Technologies’ moat lies in its proprietary and patented Fractional Thermal Oxidation-based GTL technology embodied in the G-Reformer unit, which enables modular, scalable, and portable GTL plants. This technology differentiates the company from legacy large-scale GTL plants by allowing deployment at smaller, distributed sites processing diverse natural gas sources, including flared and stranded gas. The company’s patent portfolio and exclusive licensing agreements with the University of Texas at Arlington further protect its intellectual property. Additionally, the ability to produce high purity chemicals domestically addresses supply chain dependencies on foreign manufacturers, potentially creating a niche market advantage.
• Capital Raising Risk: The company’s ability to execute its business strategy depends on raising additional debt or equity capital. Failure to secure necessary financing or unfavorable financing terms could impede operations and commercialization efforts [S1].
• Limited Operating History: As a development-stage company with limited operating history and no revenue, there is uncertainty regarding future prospects and the ability to generate sustainable revenues [S1].
• Going Concern Uncertainty: The company’s financial statements have been prepared on a going concern basis, but its ability to continue operations depends on achieving profitability or obtaining additional financing, which is uncertain [S1].
• Market Competition: The GTL industry includes large established players with significant market share. Greenway’s smaller-scale technology competes in a niche segment but faces challenges in gaining market acceptance and certification [S1].
• Technology Commercialization Risk: The proprietary GTL technology, while patented, is still in development and has not yet been widely commercialized or third-party certified, posing execution risks [S1].
Business trends: Focus on commercializing patented modular GTL technology for cleaner fuels and chemicals in the U.S. market.
Execution milestones: Progress in patent portfolio, technology demonstration, and licensing agreements; ongoing efforts to raise capital.
Key risks: Uncertainty in capital availability, limited operating history, technology commercialization challenges, and competitive market pressures.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Greenway Technologies, Inc. is engaged in research and development of proprietary gas-to-liquids (GTL) synthesis gas conversion systems and micro-plants scalable to specific gas field production requirements [S1].
- The company’s patented technology includes the G-Reformer, a component that converts natural gas into synthesis gas (Syngas), which combined with Fischer-Tropsch reactors produces fuels such as gasoline, diesel, jet fuel, methanol, and other chemicals [S1].
- Greenway also produces G-Reformers for hydrogen production and can process various natural gas streams including pipeline gas, associated gas, flared gas, vented gas, coal-bed methane, and biomass gas [S1].
- The company’s GTL technology is based on a proprietary Fractional Thermal Oxidation process and holds multiple issued patents and pending applications domestically and internationally [S1].
- Greenway’s GTL plants are modular, scalable, portable, and designed for smaller-scale, distributed deployment, differing from large refinery-scale GTL plants [S1].
- The company aims to commercialize its technology primarily in the U.S. market and to become a direct and licensed producer of renewable GTL fuels and chemicals [S1].
- Greenway’s technology produces high purity chemicals currently mostly manufactured in China, aiming to reduce dependency on foreign production [S1].
- The company has a limited operating history, is development-stage, and has incurred significant operating losses with an accumulated deficit of over $41 million as of December 31, 2025 [S1].
- As of September 30, 2026, the company reported a net loss of $400,896 for the quarter and zero revenue [S2].
- Liquidity as of September 30, 2026, shows cash and equivalents of $1,132, current assets of $3,061, and current liabilities of $15,632,444, resulting in a very low current ratio and cash ratio of 0.01 [S2].
- The company’s ability to continue as a going concern is in doubt and depends on achieving profitable operations or obtaining additional financing [S1].
- Greenway has four full-time employees, some with deferred or no compensation [S1].
- Risk factors include the uncertainty of raising additional capital, limited operating history, and the challenges inherent in commercializing new technology [S1].
- Recent news items from November 2026 relate primarily to commodity markets and other companies, with no direct news about Greenway Technologies’ operations or developments [N1][N2][N3][N4][N5][N6].
Generated 2026-11-13
- S1 | 2026-04-15 | 10-K
- S2 | 2026-11-13 | 10-Q
- N1 | 2026-11-13 | www.nasdaq.com | Cattle Rounding Out the Week with Gains | https://www.nasdaq.com/articles/cattle-rounding-out-week-gains-0
- N2 | 2026-11-13 | www.nasdaq.com | Corn Posting Friday Strength as Export Business Picks Up | https://www.nasdaq.com/articles/corn-posting-friday-strength-export-business-picks
- N3 | 2026-11-13 | www.nasdaq.com | Stocks Retreat as Chipmakers Sink and Bond Yields Rise | https://www.nasdaq.com/articles/stocks-retreat-chipmakers-sink-and-bond-yields-rise
- N4 | 2026-11-13 | www.nasdaq.com | Cotton Holding onto Friday Gains | https://www.nasdaq.com/articles/cotton-holding-friday-gains
- N5 | 2026-11-13 | www.nasdaq.com | Corn Starting Friday with Modest Gains | https://www.nasdaq.com/articles/corn-starting-friday-modest-gains
- N6 | 2026-11-13 | www.nasdaq.com | Soybeans Popping Higher on Friday Following Export Announcements | https://www.nasdaq.com/articles/soybeans-popping-higher-friday-following-export-announcements
- N7 | 2026-11-13 | www.nasdaq.com | SBC Medical (SBC) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/sbc-medical-sbc-q3-2026-earnings-call-transcript
- N8 | 2026-11-13 | www.nasdaq.com | VolitionRx (VNRX) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/volitionrx-vnrx-q3-2026-earnings-call-transcript
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


